Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2050-2055

  Harari, Paul M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT PLANNING; UNITED STATES;

EID: 0030940197     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2050     Document Type: Article

References (33)

1. Weber RS: Chemotherapy trials in head and neck cancer: Where are we, and where are we going? Head Neck 16:528-529, 1994 (editorial)
2. Weymuller EA Jr: Moratorium on multi-institutional head and neck cancer trials. Head Neck 16:529-530, 1994 (editorial)
3. Forestiere AA: A call for participation in intergroup trials. Head Neck 16:530-532, 1994 (editorial)
4. Al-Sarraf M, Hussein M: Controversies in patient management: Head and neck cancer: Present status and future prospects of adjuvant chemotherapy. Cancer Invest 13:41-53, 1995
5. Browman GP: Controversies in patient management: Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer. Cancer Invest 12:662-671, 1994
6. Dimery IW, Hong WK: Review: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993
7. Forastiere AA: Randomized trials of induction chemotherapy: A critical review. Hematol Oncol Clin North Am 5:725-736, 1991
8. Fu KK: Adjuvant chemotherapy in head and neck cancer: Promise vs. fulfillment. Int J Radiat Oncol Biol Phys 12:285-286, 1986
9. Pfister DG: Chemotherapy in locally advanced, squamous cell head and neck cancer: Limitations, lessons learned, and evolving standards of care. Cancer Invest 13:134-136, 1995
10. Rosenthal DI, Pistenmaa DA, Glatstein E: Oncology intelligence: A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 28:315-320, 1994
11. Tannock IF, Browman G: Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 4:1121-1126, 1986
12. Tannock IF: Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16:83-101, 1989
13. Tannock IF: General principles of chemotherapy, in Million RR, Cassisi NJ (eds): Management of Head and Neck Cancer: A Multidisciplinary Approach (ed 2). Philadelphia, PA, Lippincott, 1994, pp 143-156
14. Taylor SG: Why has so much chemotherapy done so little in head and neck cancer? J Clin Oncol 5:1-3, 1987
15. Urba SG, Forastiere AA: Systemic therapy of head and neck cancer: Most effective agents, areas of promise. Oncology 3:79-88, 1989
16. Vokes EE, Weichselbaum RR: Chemoradiotherapy for head and neck cancer. Prin Prac Oncol 7:1-12, 1993
17. Vokes EE, Weichselbaum RR, Lippman SM, et al: Medical progress: Head and neck cancer. N Engl J Med 328:184-194, 1993
18. Moore MJ, O'Sullivan B, Tannock IF: How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6:1736-1745, 1988
19. O'Sullivan B, Mackillop W, Gilbert R, et al: Controversies in the management of laryngeal cancer: Results of an international survey of patterns of care. Radiother Oncol 31:23-32, 1994
20. Consensus statement: The management of clinically localized prostate cancer. NIH Consensus Development Panel. NCI Monogr 7:3-7, 1988
21. Grove A: Taking on prostate cancer. Fortune May 13, 1996, pp 55-76
22. Tannock IF: Some problems related to the design and analysis of clinical trials. Int J Radiat Oncol Biol Phys 22:881-885, 1992
23. Pfister DG, Bajorin D, Motzer R, et al: Cisplatin, fluorouracil and leucovorin: Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 120:89-95, 1994
24. Vokes EE, Mick R, Lester EP, et al: Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution. J Clin Oncol 8:1376-1384, 1991
25. Al-Sarraf M, LeBlanc M, Giri PCS, et al: Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. Proc Am Soc Clin Oncol 15:313, 1996 (abstr)
26. Department of Veteran Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
27. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
28. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847, 1996
29. Munro AJ: An overview of randomized-controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
30. Stell PM, Rawson NSB: Adjuvant chemotherapy in head and neck cancer. Br J Cancer 61:779-787, 1990
31. Stell PM: Adjuvant chemotherapy for head and neck cancer. Semin Radiat Oncol 2:195-205, 1992
32. Bourhis J, Pignon JP, Domenge C: A meta-analysis of chemotherapy in head and neck cancen: An ongoing study (MACH-NC). Institut Gustave-Roussy. Paris, France. Proc Am Radium Soc 19:1995 (abstr 16)
33. Pignon JP, Bourhis J, Domenge C: Meta-analysis of chemotherapy in head and neck cancer: Individual patient data vs literature data. Br J Cancer 72:1062, 1995 (letter)